CASC3 and Miyoshi myopathy: Originally, Zhu et al. observed that FAM46C knockout had no effect on BTZ treatment in OCI-MYC5 MM cells [8], a lack of effect that was later confirmed by Herrero and colleagues in RPMI-8226 cells [30].